SE427656B - Forfarandet for framstellning av vissa fenylestrar av 13-tia-prostaglandiner - Google Patents

Forfarandet for framstellning av vissa fenylestrar av 13-tia-prostaglandiner

Info

Publication number
SE427656B
SE427656B SE7711146A SE7711146A SE427656B SE 427656 B SE427656 B SE 427656B SE 7711146 A SE7711146 A SE 7711146A SE 7711146 A SE7711146 A SE 7711146A SE 427656 B SE427656 B SE 427656B
Authority
SE
Sweden
Prior art keywords
prostaglandines
tia
establishes
procedure
preparing certain
Prior art date
Application number
SE7711146A
Other languages
English (en)
Swedish (sv)
Other versions
SE7711146L (sv
Inventor
H-E Radunz
D Orth
M Baumgarth
H-J Schliep
H-J Enenkel
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SE7711146L publication Critical patent/SE7711146L/xx
Publication of SE427656B publication Critical patent/SE427656B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/04Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0033Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/38Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/40Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
SE7711146A 1976-10-06 1977-10-05 Forfarandet for framstellning av vissa fenylestrar av 13-tia-prostaglandiner SE427656B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2644972A DE2644972C2 (de) 1976-10-06 1976-10-06 Thiaprostansäurederivate, deren Herstellung und diese Verbindungen enthaltende Mittel

Publications (2)

Publication Number Publication Date
SE7711146L SE7711146L (sv) 1978-04-07
SE427656B true SE427656B (sv) 1983-04-25

Family

ID=5989745

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7711146A SE427656B (sv) 1976-10-06 1977-10-05 Forfarandet for framstellning av vissa fenylestrar av 13-tia-prostaglandiner

Country Status (18)

Country Link
US (1) US4309441A (ja)
JP (1) JPS5346941A (ja)
AT (1) AT365170B (ja)
AU (1) AU510216B2 (ja)
BE (1) BE859423A (ja)
CA (1) CA1120927A (ja)
CH (3) CH630072A5 (ja)
DE (1) DE2644972C2 (ja)
ES (2) ES462966A1 (ja)
FR (1) FR2367061A1 (ja)
GB (1) GB1549496A (ja)
HU (1) HU178640B (ja)
IL (1) IL53050A (ja)
IT (1) IT1090237B (ja)
NL (1) NL7710931A (ja)
PT (1) PT67086B (ja)
SE (1) SE427656B (ja)
ZA (1) ZA775985B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5913723A (ja) * 1982-07-14 1984-01-24 メルク・パテント・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング 細胞保護作用を有する医薬及び13−チア−プロスタグランジン誘導体の使用
DE3401542A1 (de) * 1984-01-18 1985-08-01 Merck Patent Gmbh, 6100 Darmstadt Schwefelhaltige 6-ketoprostaglandine
DE3569728D1 (en) * 1984-03-05 1989-06-01 Teijin Ltd 7-thiaprostaglandin e 1?'s and process for their preparation
JPS63283835A (ja) * 1987-05-13 1988-11-21 Yaskawa Electric Mfg Co Ltd リニア移動装置
AU6545498A (en) 1997-03-07 1998-09-22 Alcon Laboratories, Inc. 13-thia prostaglandins for use in glaucoma therapy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH612933A5 (ja) * 1972-11-17 1979-08-31 Merck Patent Gmbh
DE2256537A1 (de) * 1972-11-17 1974-10-10 Merck Patent Gmbh Neue sulfide
US3894062A (en) * 1973-11-23 1975-07-08 Upjohn Co Substituted phenyl and naphthyl esters of PGE{HD 2
US3932486A (en) * 1974-01-08 1976-01-13 The Upjohn Company Substituted tolyl esters of PGA2
US3931285A (en) * 1974-01-08 1976-01-06 The Upjohn Company Substituted tolyl esters of PGE1
DE2422924A1 (de) * 1974-05-11 1975-11-27 Merck Patent Gmbh Thiaprostaglandine
US3994956A (en) * 1974-11-14 1976-11-30 The Upjohn Company Substituted anilide esters of 16-phenoxy and 17-phenyl PGE2 type compounds
US3998869A (en) * 1974-11-14 1976-12-21 The Upjohn Company Substituted anilide esters of 16-substituted PGE2

Also Published As

Publication number Publication date
DE2644972C2 (de) 1986-06-19
BE859423A (nl) 1978-04-06
AU510216B2 (en) 1980-06-12
JPS5346941A (en) 1978-04-27
SE7711146L (sv) 1978-04-07
AU2942677A (en) 1979-04-12
US4309441A (en) 1982-01-05
JPS6225141B2 (ja) 1987-06-01
AT365170B (de) 1981-12-28
CH640832A5 (de) 1984-01-31
CH639950A5 (de) 1983-12-15
ATA710377A (de) 1981-05-15
PT67086A (en) 1977-10-01
CA1120927A (en) 1982-03-30
FR2367061A1 (fr) 1978-05-05
IL53050A0 (en) 1977-12-30
IT1090237B (it) 1985-06-26
ES472511A1 (es) 1979-10-01
HU178640B (en) 1982-06-28
FR2367061B1 (ja) 1981-02-13
ES462966A1 (es) 1978-11-01
CH630072A5 (de) 1982-05-28
DE2644972A1 (de) 1978-04-13
GB1549496A (en) 1979-08-08
NL7710931A (nl) 1978-04-10
ZA775985B (en) 1978-05-30
IL53050A (en) 1981-12-31
PT67086B (en) 1979-02-22

Similar Documents

Publication Publication Date Title
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
SE440501B (sv) Forfarande for framstellning av substituerade fenylamidoximer
SE7700032L (sv) Framstellning av n-fosfonometylglysin
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
NO773548L (no) Fremgangsmaate for fremstilling av spiro-hydantoinderivater
NO147985C (no) Fremgangsmaate for fremstilling av meta-aryloksybenzaldehyder
SE435387B (sv) Forfarande for framstellning av antracyklinglykosider
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
SE437833B (sv) Forfarande for framstellning av 7-beta-oxiiminoacylcefalosporiner
SE431871B (sv) Forfarande for framstellning av 2-brom-6-fluor-n-2-imidazolidinylidenbensamin
SE433219B (sv) Forfarande for framstellning av 3-halogenmetylcefalosporinforeningar
SE435510B (sv) Analogiforfarande for framstellning av 3-fluor-6-piperazinylmorfantridiner
SE7707621L (sv) Forfarande for framstellning av xyloslosning
SE7707471L (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
NO774067L (no) Fremgangsmaate for fremstilling av cellulosemasse
SE7707407L (sv) Forfarande for framstellning av cefamderivat
SE7712218L (sv) Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner
SE427656B (sv) Forfarandet for framstellning av vissa fenylestrar av 13-tia-prostaglandiner
SE435380B (sv) Forfarande for framstellning av kinazolinforeningar
SE418287B (sv) Forfarande for framstellning av guajakol-p-isobutyl-hydratropat
SE7711002L (sv) Forfarande for framstellning av slipmedel
SE7706515L (sv) Forfarande for fornetning av plymerer
SE443778B (sv) Forfarande for framstellning av aryletrar av hydroxiaminer
SE7702071L (sv) Forfarande for framstellning av sulfoacetaler
SE7709142L (sv) Forfarande for framstellning av 1-aryloxi-3-amino-propan-2-oler

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7711146-6

Effective date: 19920510

Format of ref document f/p: F